Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2000 1
2003 1
2005 1
2006 3
2007 2
2008 5
2009 4
2010 6
2011 6
2012 16
2013 5
2014 9
2015 15
2016 20
2017 19
2018 29
2019 28
2020 31
2021 37
2022 31
2023 18
2024 31
2025 24
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies.
Schoevers J, Leweke JE, Leweke FM. Schoevers J, et al. Curr Opin Psychiatry. 2020 May;33(3):185-191. doi: 10.1097/YCO.0000000000000596. Curr Opin Psychiatry. 2020. PMID: 32073423 Review.
PURPOSE OF REVIEW: The most recent studies published or initiated in the last 18 months, investigating cannabidiol in the treatment of symptoms of schizophrenia and related conditions are summarized, including observed tolerability and reported side-effects. ...SUMM …
PURPOSE OF REVIEW: The most recent studies published or initiated in the last 18 months, investigating cannabidiol in the treatment o …
Improving Current Treatments for Schizophrenia.
Maric NP, Jovicic MJ, Mihaljevic M, Miljevic C. Maric NP, et al. Drug Dev Res. 2016 Nov;77(7):357-367. doi: 10.1002/ddr.21337. Epub 2016 Sep 16. Drug Dev Res. 2016. PMID: 27633376 Review.
Preclinical Research After the identification of the schizophrenia as an illness over a century ago, treatment of affected individuals included unspecific, mostly very robust methods including deep insulin coma and lobectomy/leucotomy. ...In addition, we emphasize that the …
Preclinical Research After the identification of the schizophrenia as an illness over a century ago, treatment of affected individual …
Does cannabidiol have a role in the treatment of schizophrenia?
Gururajan A, Malone DT. Gururajan A, et al. Schizophr Res. 2016 Oct;176(2-3):281-290. doi: 10.1016/j.schres.2016.06.022. Epub 2016 Jul 1. Schizophr Res. 2016. PMID: 27374322 Review.
Schizophrenia is a debilitating psychiatric disorder which places a significant emotional and economic strain on the individual and society-at-large. Unfortunately, currently available therapeutic strategies do not provide adequate relief and some patients are treatment-re …
Schizophrenia is a debilitating psychiatric disorder which places a significant emotional and economic strain on the individual and s …
Is cannabidiol an effective treatment for schizophrenia?
Guinguis R, Ruiz MI, Rada G. Guinguis R, et al. Medwave. 2017 Aug 9;17(7):e7010. doi: 10.5867/medwave.2017.07.7010. Medwave. 2017. PMID: 28820868 English, Spanish.
Cannabidiol has recently been proposed as an antipsychotic for schizophrenia. However, its clinical use and safety is controversial. ...We extracted data from the systematic reviews, reanalyzed data from primary studies, conducted a meta-analysis and generated a sum …
Cannabidiol has recently been proposed as an antipsychotic for schizophrenia. However, its clinical use and safety is controve …
Investigating Cannabidiol's potential as a supplementary treatment for schizophrenia: A narrative review.
Denis Völker JS, Micluția IV, Vinași RC. Denis Völker JS, et al. Eur J Pharmacol. 2024 Sep 15;979:176821. doi: 10.1016/j.ejphar.2024.176821. Epub 2024 Jul 27. Eur J Pharmacol. 2024. PMID: 39068976 Review.
Schizophrenia presents a complex mental health challenge, often inadequately addressed by existing antipsychotic treatments, leading to persistent symptoms and adverse effects. Hence, developing alternative therapeutic approaches is crucial. Cannabidiol (CBD), a non …
Schizophrenia presents a complex mental health challenge, often inadequately addressed by existing antipsychotic treatments, leading …
The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis.
Kopelli E, Samara M, Siargkas A, Goulas A, Papazisis G, Chourdakis M. Kopelli E, et al. Psychiatry Res. 2020 Sep;291:113246. doi: 10.1016/j.psychres.2020.113246. Epub 2020 Jun 22. Psychiatry Res. 2020. PMID: 32599446
The purpose of the present meta-analysis was to assess the efficacy of cannabidiol (CBD) oil in patients with schizophrenia. A search was conducted in EMBASE, PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov and WHO International …
The purpose of the present meta-analysis was to assess the efficacy of cannabidiol (CBD) oil in patients with schizophrenia. A …
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Loss CM, Teodoro L, Rodrigues GD, Moreira LR, Peres FF, Zuardi AW, Crippa JA, Hallak JEC, Abílio VC. Loss CM, et al. Front Pharmacol. 2021 Feb 4;11:635763. doi: 10.3389/fphar.2020.635763. eCollection 2020. Front Pharmacol. 2021. PMID: 33613289 Free PMC article. Review.
Schizophrenia and autism spectrum disorders (ASD) are psychiatric neurodevelopmental disorders that cause high levels of functional disabilities. ...Preclinical and clinical evidence points to cannabidiol (CBD) as a promising strategy. In this review, we discuss cli …
Schizophrenia and autism spectrum disorders (ASD) are psychiatric neurodevelopmental disorders that cause high levels of functional d …
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Garakani A, et al. Front Psychiatry. 2020 Dec 23;11:595584. doi: 10.3389/fpsyt.2020.595584. eCollection 2020. Front Psychiatry. 2020. PMID: 33424664 Free PMC article. Review.
While there continues to be expansive research in posttraumatic stress disorder (PTSD), depression and schizophrenia, there is a relative dearth of novel medications under investigation for anxiety disorders. ...Although there are some recent randomized controlled trials f …
While there continues to be expansive research in posttraumatic stress disorder (PTSD), depression and schizophrenia, there is a rela …
Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits.
Hoch E, Volkow ND, Friemel CM, Lorenzetti V, Freeman TP, Hall W. Hoch E, et al. Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):281-292. doi: 10.1007/s00406-024-01880-2. Epub 2024 Sep 19. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 39299947 Free PMC article. Review.
Chronic patterns of cannabis use have been associated with multiple adverse outcomes that are of particular concern among adolescents and young adults, such as, disrupted learning, impaired cognitive performance, reduced educational attainment and an increased risk of CUD, psycho …
Chronic patterns of cannabis use have been associated with multiple adverse outcomes that are of particular concern among adolescents and yo …
Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment.
Ghabrash MF, Coronado-Montoya S, Aoun J, Gagné AA, Mansour F, Ouellet-Plamondon C, Trépanier A, Jutras-Aswad D. Ghabrash MF, et al. Psychiatry Res. 2020 Apr;286:112890. doi: 10.1016/j.psychres.2020.112890. Epub 2020 Feb 21. Psychiatry Res. 2020. PMID: 32126328 Review.
Current treatments for primary psychotic disorders include antipsychotics, some of which have significant side effects or suboptimal efficacy. Cannabidiol is a cannabinoid with potential antipsychotic properties. This systematic review examines the use of cannabidiol …
Current treatments for primary psychotic disorders include antipsychotics, some of which have significant side effects or suboptimal efficac …
306 results